We have recently showed that patients with PMF have an increased frequency of circulating CD34+/CD133+/VEGFR2+ cells as compared to the patients with Ph-neg chronic MPNs (Polycythemia Vera, PV and Essential Thrombocythemia, ET) and healthy subjects [3]. This evidence concerns the gene PROM1 and essential thrombocythemia.